Our study revealed that TRIB3 plays an important role in the promotion of glioma development and progression by suppressing autophagic flux, which drives the invasion and proliferation of GBM cells, suggesting that TRIB3 is a potential novel therapeutic target for the treatment of glioma. This evidence concerns the gene TRIB3 and glioblastoma.